CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +21,288 | $72.42 | $1.5M | 77,516 |
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +8,491 | $44.70 | $380K | 86,007 |
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +8,491 | $47.81 | $406K | 94,498 |
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +8,491 | $38.41 | $326K | 102,989 |
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Sale | −45,910 | $78.88 | $3.6M | 57,079 |
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Option (right to buy) | −5,843 | 0 | ||
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Option (right to buy) | −21,288 | 0 | ||
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Option (right to buy) | −8,491 | 0 | ||
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Option (right to buy) | −8,491 | 0 | ||
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Option (right to buy) | −8,491 | 0 | ||
| 2022-09-30 | Rice Derica W Director | Grant or award · Deferred Share Units | +509.92 | $71.09 | $36K | 12,001.39 |
| 2022-09-30 | Storch Gerald L Director | Grant or award · Deferred Share Units | +509.92 | $71.09 | $36K | 73,028.78 |
| 2022-09-30 | Bhatt Deepak Director | Grant or award · Deferred Share Units | +105.5 | $71.09 | $7K | 1,873.52 |
| 2022-09-30 | Haller Julia A Director | Grant or award · Deferred Share Units | +474.75 | $71.09 | $34K | 16,244.25 |
| 2022-09-30 | Hidalgo Medina Manuel Director | Grant or award · Deferred Share Units | +118.69 | $71.09 | $8K | 5,757.01 |
| 2022-09-30 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +685.75 | $71.09 | $49K | 33,712.29 |
| 2022-09-30 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +474.75 | $71.09 | $34K | 15,988.03 |
| 2022-09-30 | Arduini Peter J Director | Grant or award · Deferred Share Units | +474.75 | $71.09 | $34K | 39,740.31 |
| 2022-09-20 | Caforio Giovanni Board Chair and CEO | Sale | −25,000 | $69.71 | $1.7M | 476,104.33 |
| 2022-09-15 | Caforio Giovanni Board Chair and CEO | Sale | −50,000 | $71.84 | $3.6M | 501,104.33 |
Page 54 of 56 · 1,112 trades